带有腹膜透析和血液透析的积极组合治疗对技术生存率和死亡率的影响
Kei Nagai1,2, Atsushi Ueda3
1Department of Nephrology, Hitachi General Hospital, 2-1-1 Johnan-Cho, Hitachi, Ibaraki, 317-0077, Japan. knagai@md.tsukuba.ac.jp.
概括
在诱导阶段开始腹膜透析和血液透析的联合治疗可能会延长联合治疗期,但不一定延长腹膜透析技术的存活率. 需要进一步的研究来证实这些发现.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 脏替代疗法治疗 脏替代疗法
- 透析方式 透析方式
背景情况:
- 关于启动组合治疗 (腹膜透析和血液透析) 的最佳时间的证据有限.
- 组合疗法旨在利用这两种透析方式的好处.
研究的目的:
- 追溯调查在腹膜透析的诱导阶段开始组合治疗是否可以延长其持续时间.
- 评估组合疗法启动时间对技术生存,死亡率和心血管事件住院治疗的影响.
主要方法:
- 一项涉及20个透析设施160名患者的回顾性研究.
- 根据组合治疗开始的时间,患者被分为四组:主动 (诱导时) 和经过 <2,2-5或>5年的腹膜透析后.
- 分析的结果包括透析技术的生存率,死亡率和心血管事件的住院治疗.
主要成果:
- 积极组的组合疗法平均持续时间较长 (3.18年) 与较晚开始 (1.45年) 相比.
- 然而,在主动组 (4.02年) 中,腹膜透析的总持续时间较短.
- 主动组显示原始死亡率和缺血性心脏病住院率较低,但该研究缺乏统计能力来得出明确的结论.
结论:
- 在诱导阶段开始组合治疗可能会延长组合治疗本身的持续时间.
- 这种早期启动似乎并没有在延长腹膜透析技术存活时间方面具有明确的有效性.
- 需要进一步的强有力的研究来澄清与组合治疗启动时间相关的临床结果.
相关概念视频
01:27Dialysis
307
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
307
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:24Kaplan-Meier Approach
136
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
136
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:20Comparing the Survival Analysis of Two or More Groups
181
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
181